person · Reporting owner
Cooperatieve Gilde Healthcare IV U.A.
Disclosed activity across 3 companies
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (3)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Axonics, Inc.
Report date November 21, 2019 · Filed December 10, 2019
Jointly reported with Gilde Healthcare Holding B.V., Gilde Healthcare IV Management B.V.
Section 16 reporting ended · disclosed 2019-12-10. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Inari Medical, Inc.
Report date March 12, 2021 · Filed March 16, 2021
Jointly reported with Gilde Healthcare IV Management B.V., Gilde Healthcare Holding B.V.
Section 16 reporting ended · disclosed 2021-03-16. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 4,491,679 |
Last balance in matching sequence
After 2021-03-15 transaction · row 13
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
13 source rowsRow 1 · 2021-03-12 · Sale · Disposed 47,935 · Balance 5,893,744 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $114.45 to $115.44, inclusive. The Reporting Persons undertake to provide to Inari Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Row 2 · 2021-03-12 · Sale · Disposed 113,990 · Balance 5,779,754 F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $115.45 to $116.44, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Row 3 · 2021-03-12 · Sale · Disposed 32,926 · Balance 5,746,828 F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $116.45 to $117.445, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Row 4 · 2021-03-12 · Sale · Disposed 18,700 · Balance 5,728,128 F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $117.45 to $118.40, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Row 5 · 2021-03-12 · Sale · Disposed 24,689 · Balance 5,703,439 F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $118.47 to $119.42, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Row 6 · 2021-03-12 · Sale · Disposed 11,760 · Balance 5,691,679 F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $119.575 to $120.00, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Row 7 · 2021-03-15 · Sale · Disposed 4,707 · Balance 5,686,972 F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $112.655 to $113.63, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Row 8 · 2021-03-15 · Sale · Disposed 89,169 · Balance 5,597,803 F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $113.67 to $114.665, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Row 9 · 2021-03-15 · Sale · Disposed 49,316 · Balance 5,548,487 F10: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $114.6775 to $115.66, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Row 10 · 2021-03-15 · Sale · Disposed 33,799 · Balance 5,514,688 F11: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $115.67 to $116.66, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Row 11 · 2021-03-15 · Sale · Disposed 20,663 · Balance 5,494,025 F12: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $116.67 to $117.61, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Row 12 · 2021-03-15 · Sale · Disposed 2,346 · Balance 5,491,679 F13: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $117.71 to $118.31, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Row 13 · 2021-03-15 · Sale · Disposed 1,000,000 · Balance 4,491,679 F2: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $114.45 to $115.44, inclusive. The Reporting Persons undertake to provide to Inari Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F2: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $115.45 to $116.44, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $116.45 to $117.445, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $117.45 to $118.40, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $118.47 to $119.42, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $119.575 to $120.00, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $112.655 to $113.63, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $113.67 to $114.665, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F10: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $114.6775 to $115.66, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F11: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $115.67 to $116.66, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F12: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $116.67 to $117.61, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F13: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $117.71 to $118.31, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
LAVA Therapeutics NV
Report date October 16, 2025 · Filed October 20, 2025
Jointly reported with Gilde Healthcare Holding B.V.
Section 16 reporting ended · disclosed 2025-10-20. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 4,128,912 |
Reported balance
After 2025-10-16 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2025-10-16 · Sale · Disposed 690,239 · Balance 4,128,912 F1: This figure is the weighted average sales price of multiple trades ranging from $1.47 to $1.53 per share. The Reporting Person undertakes to provide the Staff of the Securities and Exchange Commission, LAVA Therapeutics NV or any security holder of LAVA Therapeutics NV full information about the number of shares sold at each separate price upon request. F2: The shares are held directly by Cooperatieve Gilde Healthcare IV U.A. ("Gilde Healthcare"). Gilde Healthcare IV Management BV ("GHCIVM") manages and advises Gilde Healthcare and is owned by Gilde Healthcare Holding BV ("GHH"). Each of GHCIVM and GHH disclaims beneficial ownership of the shares held by Gilde Healthcare, except to the extent of its respective pecuniary interests therein. |
| Common SharesSEC Table I · non-derivative | Direct | 2,947,781 |
Reported balance
After 2025-10-17 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2025-10-17 · Sale · Disposed 1,181,131 · Balance 2,947,781 F3: This figure is the weighted average sales price of multiple trades ranging from $1.44 to $1.52 per share. The Reporting Person undertakes to provide the Staff of the Securities and Exchange Commission, LAVA Therapeutics NV or any security holder of LAVA Therapeutics NV full information about the number of shares sold at each separate price upon request. F2: The shares are held directly by Cooperatieve Gilde Healthcare IV U.A. ("Gilde Healthcare"). Gilde Healthcare IV Management BV ("GHCIVM") manages and advises Gilde Healthcare and is owned by Gilde Healthcare Holding BV ("GHH"). Each of GHCIVM and GHH disclaims beneficial ownership of the shares held by Gilde Healthcare, except to the extent of its respective pecuniary interests therein. |
| Common SharesSEC Table I · non-derivative | Direct | 1,947,781 |
Reported balance
After 2015-10-20 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2015-10-20 · Sale · Disposed 1,000,000 · Balance 1,947,781 F4: This figure is the weighted average sales price of multiple trades ranging from $1.44 to $1.51 per share. The Reporting Person undertakes to provide the Staff of the Securities and Exchange Commission, LAVA Therapeutics NV or any security holder of LAVA Therapeutics NV full information about the number of shares sold at each separate price upon request. F2: The shares are held directly by Cooperatieve Gilde Healthcare IV U.A. ("Gilde Healthcare"). Gilde Healthcare IV Management BV ("GHCIVM") manages and advises Gilde Healthcare and is owned by Gilde Healthcare Holding BV ("GHH"). Each of GHCIVM and GHH disclaims beneficial ownership of the shares held by Gilde Healthcare, except to the extent of its respective pecuniary interests therein. |
Filing footnotes · ownership attribution and instrument terms
F1: This figure is the weighted average sales price of multiple trades ranging from $1.47 to $1.53 per share. The Reporting Person undertakes to provide the Staff of the Securities and Exchange Commission, LAVA Therapeutics NV or any security holder of LAVA Therapeutics NV full information about the number of shares sold at each separate price upon request.
F2: The shares are held directly by Cooperatieve Gilde Healthcare IV U.A. ("Gilde Healthcare"). Gilde Healthcare IV Management BV ("GHCIVM") manages and advises Gilde Healthcare and is owned by Gilde Healthcare Holding BV ("GHH"). Each of GHCIVM and GHH disclaims beneficial ownership of the shares held by Gilde Healthcare, except to the extent of its respective pecuniary interests therein.
F3: This figure is the weighted average sales price of multiple trades ranging from $1.44 to $1.52 per share. The Reporting Person undertakes to provide the Staff of the Securities and Exchange Commission, LAVA Therapeutics NV or any security holder of LAVA Therapeutics NV full information about the number of shares sold at each separate price upon request.
F4: This figure is the weighted average sales price of multiple trades ranging from $1.44 to $1.51 per share. The Reporting Person undertakes to provide the Staff of the Securities and Exchange Commission, LAVA Therapeutics NV or any security holder of LAVA Therapeutics NV full information about the number of shares sold at each separate price upon request.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 10, 2020 Filed Dec 14, 2020 17:22 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 29,444 | $67.81 | $1,996,597.64 |
DisclosureSEC source: 0000899243-20-033761 · doc4.xml · nonDerivative · entry 2 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 7,111,305 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $67.46 to $68.00, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 10, 2020 Filed Dec 14, 2020 17:22 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 8,419 | $67.04 | $564,409.76 |
DisclosureSEC source: 0000899243-20-033761 · doc4.xml · nonDerivative · entry 1 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 7,140,749 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $66.46 to $67.45 inclusive. The Reporting Persons undertake to provide to Inari Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 09, 2020 Filed Dec 9, 2020 18:41 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 5,729 | $67.33 | $385,733.57 |
DisclosureSEC source: 0000899243-20-033193 · doc4.xml · nonDerivative · entry 5 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 7,149,168 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $67.21 to $67.57, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 09, 2020 Filed Dec 9, 2020 18:41 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 112,780 | $66.75 | $7,528,065.00 |
DisclosureSEC source: 0000899243-20-033193 · doc4.xml · nonDerivative · entry 4 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 7,154,897 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $66.21 to $67.205, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 09, 2020 Filed Dec 9, 2020 18:41 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 36,715 | $65.88 | $2,418,784.20 |
DisclosureSEC source: 0000899243-20-033193 · doc4.xml · nonDerivative · entry 3 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 7,267,677 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $65.21 to $66.205, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 08, 2020 Filed Dec 9, 2020 18:41 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 28,677 | $65.35 | $1,874,041.95 |
DisclosureSEC source: 0000899243-20-033193 · doc4.xml · nonDerivative · entry 2 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 7,304,392 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $65.00 to $65.73, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 18:41 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 70,939 | $65.10 | $4,618,128.90 |
DisclosureSEC source: 0000899243-20-033193 · doc4.xml · nonDerivative · entry 1 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 7,333,069 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $65.00 to $65.58 inclusive. The Reporting Persons undertake to provide to Inari Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 04, 2020 Filed Dec 4, 2020 18:59 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 14,482 | $65.01 | $941,474.82 |
DisclosureSEC source: 0000899243-20-032786 · doc4.xml · nonDerivative · entry 6 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 7,404,008 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $65.00 to $65.24, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 03, 2020 Filed Dec 4, 2020 18:59 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 1,620 | $65.03 | $105,348.60 |
DisclosureSEC source: 0000899243-20-032786 · doc4.xml · nonDerivative · entry 5 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 7,418,490 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $65.00 to $65.165, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 18:59 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 21,569 | $65.04 | $1,402,847.76 |
DisclosureSEC source: 0000899243-20-032786 · doc4.xml · nonDerivative · entry 4 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 7,420,110 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $65.00 to $65.21, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 18:59 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 4,102 | $65.50 | $268,681.00 |
DisclosureSEC source: 0000899243-20-032786 · doc4.xml · nonDerivative · entry 3 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 7,441,679 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $65.305 to $66.25, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 18:59 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 49,515 | $64.89 | $3,213,028.35 |
DisclosureSEC source: 0000899243-20-032786 · doc4.xml · nonDerivative · entry 2 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 7,445,781 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $64.30 to $65.285, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 18:59 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 3,839 | $63.81 | $244,966.59 |
DisclosureSEC source: 0000899243-20-032786 · doc4.xml · nonDerivative · entry 1 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 7,495,296 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $63.30 to $64.285, inclusive. The Reporting Persons undertake to provide to Inari Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 01, 2020 Filed Dec 1, 2020 20:04 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 2,818 | $69.07 | $194,639.26 |
DisclosureSEC source: 0000899243-20-032404 · doc4.xml · nonDerivative · entry 10 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 7,499,135 F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $68.50 to $69.31, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 01, 2020 Filed Dec 1, 2020 20:04 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 73,435 | $67.93 | $4,988,439.55 |
DisclosureSEC source: 0000899243-20-032404 · doc4.xml · nonDerivative · entry 9 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 7,501,953 F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $67.49 to $68.31, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 01, 2020 Filed Dec 1, 2020 20:04 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 88,435 | $67.06 | $5,930,451.10 |
DisclosureSEC source: 0000899243-20-032404 · doc4.xml · nonDerivative · entry 8 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 7,575,388 F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $66.49 to $67.4875, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| November 30, 2020 Filed Dec 1, 2020 20:04 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 39,955 | $68.81 | $2,749,303.55 |
DisclosureSEC source: 0000899243-20-032404 · doc4.xml · nonDerivative · entry 7 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 7,663,823 F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $68.30 to $69.15, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| November 30, 2020 Filed Dec 1, 2020 20:04 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 78,696 | $67.74 | $5,330,867.04 |
DisclosureSEC source: 0000899243-20-032404 · doc4.xml · nonDerivative · entry 6 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 7,703,778 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $67.30 to $68.28, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| November 30, 2020 Filed Dec 1, 2020 20:04 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 65,795 | $66.94 | $4,404,317.30 |
DisclosureSEC source: 0000899243-20-032404 · doc4.xml · nonDerivative · entry 5 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 7,782,474 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $66.29 to $67.275, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| November 30, 2020 Filed Dec 1, 2020 20:04 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 14,770 | $65.81 | $972,013.70 |
DisclosureSEC source: 0000899243-20-032404 · doc4.xml · nonDerivative · entry 4 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 7,848,269 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $65.28 to $66.27, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| November 27, 2020 Filed Dec 1, 2020 20:04 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 53,484 | $68.94 | $3,687,186.96 |
DisclosureSEC source: 0000899243-20-032404 · doc4.xml · nonDerivative · entry 3 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 7,863,039 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $68.56 to $69.50, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| November 27, 2020 Filed Dec 1, 2020 20:04 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 11,200 | $68.28 | $764,736.00 |
DisclosureSEC source: 0000899243-20-032404 · doc4.xml · nonDerivative · entry 2 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 7,916,523 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $67.565 to $68.55, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| November 27, 2020 Filed Dec 1, 2020 20:04 UTC | Inari Medical, Inc. NARI · Entity 83035 | SaleCommon Stock | 13,956 | $66.99 | $934,912.44 |
DisclosureSEC source: 0000899243-20-032404 · doc4.xml · nonDerivative · entry 1 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 7,927,723 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $66.555 to $67.41, inclusive. The Reporting Persons undertake to provide to Inari Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| May 27, 2020 Filed May 27, 2020 18:21 UTC | Inari Medical, Inc. NARI · Entity 83035 | ConversionSeries C Preferred Stock · Derivative | 7,599,350 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-032399 · doc4.xml · derivative · entry 3 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 7,599,350 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one basis. F2 · price: Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one basis. F2 · derivative.exercise_date: Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one basis. F2 · derivative.expiration_date: Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one basis. F1 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| May 27, 2020 Filed May 27, 2020 18:21 UTC | Inari Medical, Inc. NARI · Entity 83035 | ConversionCommon Stock | 7,599,350 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-032399 · doc4.xml · nonDerivative · entry 2 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 7,941,679 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one basis. F2 · price: Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one basis. F1 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| May 27, 2020 Filed May 27, 2020 18:21 UTC | Inari Medical, Inc. NARI · Entity 83035 | PurchaseCommon Stock | 342,329 | $19.00 | $6,504,251.00 |
DisclosureSEC source: 0001209191-20-032399 · doc4.xml · nonDerivative · entry 1 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 342,329 F1 · ownership.nature: All securities reported are held of record by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Gilde is managed by Gilde Healthcare IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein. Read SEC document |
| November 02, 2018 Filed Nov 2, 2018 19:34 UTC | Axonics, Inc. AXNX · Entity 86004 | ConversionSeries C Preferred Stock · Derivative | 1,888,888 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-028091 · doc4.xml · derivative · entry 3 Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Cooperatieve Gilde Healthcare IV U.A. Disclosed balance after: 0 Underlying: Common Stock · 2,266,666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Effective upon the closing of the Issuer's initial public offering of its common stock under the Securities Act of 1933, as amended, each share of Series C preferred stock automatically converted into 1.2 shares of the Issuer's common stock. The Series C preferred stock had no expiration date. F2 · derivative.exercise_date: Effective upon the closing of the Issuer's initial public offering of its common stock under the Securities Act of 1933, as amended, each share of Series C preferred stock automatically converted into 1.2 shares of the Issuer's common stock. The Series C preferred stock had no expiration date. F2 · derivative.expiration_date: Effective upon the closing of the Issuer's initial public offering of its common stock under the Securities Act of 1933, as amended, each share of Series C preferred stock automatically converted into 1.2 shares of the Issuer's common stock. The Series C preferred stock had no expiration date. F1 · derivative.underlying_shares: Reflects a 1.2-for-1 forward stock split of the Issuer's common stock effected on October 18, 2018. F3 · ownership.nature: The shares are held directly by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Geoff Pardo ("Pardo"), who is a member of the Issuer's board of directors, is a partner of Gilde. Gilde is managed IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Pardo, Management and Holding may be deemed to have voting, investment and dispositive power with respect to these securities. Each of Pardo, Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| November 02, 2018 Filed Nov 2, 2018 19:34 UTC | Axonics, Inc. AXNX · Entity 86004 | PurchaseCommon Stock | 866,666 | $15.00 | $12,999,990.00 |
DisclosureSEC source: 0000899243-18-028091 · doc4.xml · nonDerivative · entry 2 Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Cooperatieve Gilde Healthcare IV U.A. Disclosed balance after: 3,133,332 F1 · shares: Reflects a 1.2-for-1 forward stock split of the Issuer's common stock effected on October 18, 2018. F1 · balance_after: Reflects a 1.2-for-1 forward stock split of the Issuer's common stock effected on October 18, 2018. F3 · ownership.nature: The shares are held directly by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Geoff Pardo ("Pardo"), who is a member of the Issuer's board of directors, is a partner of Gilde. Gilde is managed IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Pardo, Management and Holding may be deemed to have voting, investment and dispositive power with respect to these securities. Each of Pardo, Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| November 02, 2018 Filed Nov 2, 2018 19:34 UTC | Axonics, Inc. AXNX · Entity 86004 | ConversionCommon Stock | 2,266,666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-18-028091 · doc4.xml · nonDerivative · entry 1 Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Gilde Healthcare IV Management B.V. · CIK 0001757508 · 10% owner Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Cooperatieve Gilde Healthcare IV U.A. Disclosed balance after: 2,266,666 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects a 1.2-for-1 forward stock split of the Issuer's common stock effected on October 18, 2018. F2 · price: Effective upon the closing of the Issuer's initial public offering of its common stock under the Securities Act of 1933, as amended, each share of Series C preferred stock automatically converted into 1.2 shares of the Issuer's common stock. The Series C preferred stock had no expiration date. F1 · balance_after: Reflects a 1.2-for-1 forward stock split of the Issuer's common stock effected on October 18, 2018. F3 · ownership.nature: The shares are held directly by Cooperatieve Gilde Healthcare IV U.A. ("Gilde"). Geoff Pardo ("Pardo"), who is a member of the Issuer's board of directors, is a partner of Gilde. Gilde is managed IV Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Pardo, Management and Holding may be deemed to have voting, investment and dispositive power with respect to these securities. Each of Pardo, Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| October 20, 2015 Filed Oct 20, 2025 22:58 UTC | LAVA Therapeutics NV LVTX · Entity 73047 | SaleCommon Shares | 1,000,000 | $1.46 | $1,460,000.00 |
DisclosureSEC source: 0001193125-25-243899 · ownership.xml · nonDerivative · entry 3 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,947,781 F4 · price: This figure is the weighted average sales price of multiple trades ranging from $1.44 to $1.51 per share. The Reporting Person undertakes to provide the Staff of the Securities and Exchange Commission, LAVA Therapeutics NV or any security holder of LAVA Therapeutics NV full information about the number of shares sold at each separate price upon request. F2 · ownership.direct: The shares are held directly by Cooperatieve Gilde Healthcare IV U.A. ("Gilde Healthcare"). Gilde Healthcare IV Management BV ("GHCIVM") manages and advises Gilde Healthcare and is owned by Gilde Healthcare Holding BV ("GHH"). Each of GHCIVM and GHH disclaims beneficial ownership of the shares held by Gilde Healthcare, except to the extent of its respective pecuniary interests therein. Read SEC document |
| October 15, 2015 Filed Oct 16, 2025 00:56 UTC | LAVA Therapeutics NV LVTX · Entity 73047 | SaleCommon Shares | 200,000 | $1.51 | $302,000.00 |
DisclosureSEC source: 0001193125-25-240610 · ownership.xml · nonDerivative · entry 3 Cooperatieve Gilde Healthcare IV U.A. · CIK 0001756335 · 10% owner Gilde Healthcare Holding B.V. · CIK 0001420106 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,819,151 F4 · price: This figure is the weighted average sales price of multiple trades ranging from $1.49 to $1.54 per share. The Reporting Person undertakes to provide the Staff of the Securities and Exchange Commission, LAVA Therapeutics NV or any security holder of LAVA Therapeutics NV full information about the number of shares sold at each separate price upon request. F2 · ownership.direct: The shares are held directly by Cooperatieve Gilde Healthcare IV U.A. ("Gilde Healthcare"). Gilde Healthcare IV Management BV ("GHCIVM") manages and advises Gilde Healthcare and is owned by Gilde Healthcare Holding BV ("GHH"). Each of GHCIVM and GHH disclaims beneficial ownership of the shares held by Gilde Healthcare, except to the extent of its respective pecuniary interests therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.